Shanghai – September 11, 2026 -- Alebund Pharmaceuticals (Jiangsu) Limited (HKEX: 09637) has received U.S. FDA clearance of its Investigational New Drug application for AP308, a first-in-class engineered recombinant IgA protease targeting IgA Nephropathy (IgAN), moving the candidate from preclinical research into clinical development.

United States – September 11, 2026 -- Observe.AI has launched Performance Agents, an AI system that cuts contact center coaching preparation time to under five minutes in applicable workflows, the company announced.

United States – September 11, 2026 -- Observe.AI has launched Performance Agents, an AI system that cuts contact center coaching preparation time to under five minutes in applicable workflows, the company announced.

San Antonio – September 11, 2026 -- Safehold Inc. (NYSE: SAFE) has closed on a ground lease to develop a 336-unit Low-Income Housing Tax Credit community in San Antonio, Texas, marking its third Affordable Housing transaction in the state this year.

San Antonio – September 11, 2026 -- Safehold Inc. (NYSE: SAFE) has closed on a ground lease to develop a 336-unit Low-Income Housing Tax Credit community in San Antonio, Texas, marking its third Affordable Housing transaction in the state this year.

Tonopah, Nevada – September 11, 2026 -- A2Gold Corp. (TSXV: AUAU) (OTCQX: AUXXF) (FRA: RR7) has completed 15 reverse-circulation drill holes totaling approximately 4,400 metres at its Taylor Gold-Silver Project in White Pine County, Nevada, marking the company's first drill campaign at the site since acquiring it earlier in 2026.

Tonopah, Nevada – September 11, 2026 -- A2Gold Corp. (TSXV: AUAU) (OTCQX: AUXXF) (FRA: RR7) has completed 15 reverse-circulation drill holes totaling approximately 4,400 metres at its Taylor Gold-Silver Project in White Pine County, Nevada, marking the company's first drill campaign at the site since acquiring it earlier in 2026.

Washington – September 11, 2026 -- Quantinuum has finalized a $100 million federal funding agreement with the US Department of Commerce's CHIPS Research and Development Office, becoming the only trapped-ion quantum computing company to receive funds under the CHIPS and Science Act's R&D program.

Washington – September 11, 2026 -- Quantinuum has finalized a $100 million federal funding agreement with the US Department of Commerce's CHIPS Research and Development Office, becoming the only trapped-ion quantum computing company to receive funds under the CHIPS and Science Act's R&D program.

Washington – September 11, 2026 -- Quantinuum has finalized a $100 million funding agreement with the U.S. Department of Commerce's CHIPS Research and Development Office, marking the first CHIPS for R&D award granted to a trapped-ion quantum computing architecture company.